Anti-malarial anti-cholesterol drugs

US researchers say that adding cholesterol-lowering drugs to malaria therapy helps counter cognitive decline in rats with cerebral malaria, according to UPI news agency.

Mosquitoes, vectors of parasites causing malaria

Studies on children with cerebral malaria showed cognitive defects, such as memory impairment, learning, language and mathematics, for a long time after treatment. malaria, which is caused by the Plasmodium falciparum parasite through an intermediary is a mosquito.

Dr. Guy Zimmerman of the University of Utah (USA) and colleagues evaluated the effect of statins, the drug used to lower cholesterol, in rats with cerebral malaria.

Experts found that the addition of lovastatin to traditional malaria therapy prevented cognitive dysfunction in rats with cerebral malaria.

The research results are published in PLOS Pathogens.